Nabiha Saklayen, PhD
FounderCo-Founder & CEO at Cellino Bio
Cambridge, Massachusetts, United States
FoundedCellino Bio
About
Nabiha Saklayen is a co-founder and Chief Product & Regulatory Officer at Cellino, a venture-backed biotech company developing biomanufacturing technology to scale production of personalized iPSC-based therapies, where she leads regulatory strategy including the Advanced Manufacturing Technology designation request granted by the FDA in May 2025. She holds a PhD and MA in Applied Physics from Harvard University, where she co-invented laser-based intracellular delivery techniques, and a BSc in Biophysics from the University of California, Los Angeles, after transferring from Riverside Community College. She holds several patents, has authored peer-reviewed publications including the first review paper on autologous iPSC-based cell therapies, and was named to the Forbes 30 Under 30 2019 list for Healthcare.
Co-Founder & CEO at Cellino Bio
Intro paths
In turn, Nabiha can intro founders to Cellino Bio's investors below.
Cellino Bio's investors Β· 7
Co-founders at Cellino Bio
Experience
- CellinoCo-Founder, Chief Product & Regulatory Officercurrent2026 β presentCambridge, Massachusetts, United States
- CellinoCo-Founder, Chief Product Officer2022 β 2026Cambridge, Massachusetts, United States
- CellinoCo-Founder2017 β 2022Cambridge, MA, USA
- International Society for Stem Cell ResearchCommittee Member - Manufacturing, Clinical Translation, and Regulatory Committeecurrent2024 β present
- ISCT, International Society for Cell & Gene TherapyInvited Committee Member - JSRM-ISCT iPSC Committeecurrent2022 β present
- Autologous iPSC-based Cell Therapy ConsortiumMembercurrent2020 β present
- Global Alliance for iPSC Therapies (GAiT)Invited Committee Member - Industry Liaison Committeecurrent2021 β present
Skills & more
From Nabiha's professional profile.
Frequently asked questions
- Who is Nabiha Saklayen, PhD?
- Nabiha Saklayen is a co-founder and Chief Product & Regulatory Officer at Cellino, a venture-backed biotech company developing biomanufacturing technology to scale production of personalized iPSC-based therapies, where she leads regulatory strategy including the Advanced Manufacturing Technology designation request granted by the FDA in May 2025. She holds a PhD and MA in Applied Physics from Harvard University, where she co-invented laser-based intracellular delivery techniques, and a BSc in Biophysics from the University of California, Los Angeles, after transferring from Riverside Community College. She holds several patents, has authored peer-reviewed publications including the first review paper on autologous iPSC-based cell therapies, and was named to the Forbes 30 Under 30 2019 list for Healthcare.
- Where does Nabiha Saklayen, PhD work?
- Nabiha Saklayen, PhD is Co-Founder & CEO of Cellino Bio.
- What companies did Nabiha Saklayen, PhD found?
- Nabiha Saklayen, PhD founded Cellino Bio.
- Where did Nabiha Saklayen, PhD go to school?
- Nabiha Saklayen, PhD studied at Harvard University (PhD, Applied Physics); Riverside City College; UCLA (BS, Physics/ Biophysics).
Same school
Also attended Harvard University1,970
+ 1,964 more
Also attended UCLA680
+ 674 more
Shared employers
Also worked at Cellino7
+ 1 more





















